Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

PCOS is a common disorder in women causing symptoms like irregular periods and weight gain, with management possible through lifestyle changes and medication.

Some aggressive scalp cancers are hard to treat and can be deadly, even when removed with specialized surgery.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Testosterone may influence COVID-19 severity and outcomes.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

New cancer treatments aim to reduce side effects and improve effectiveness.

Invasomes effectively deliver drugs through the skin and have potential for improved treatments.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

LGR5 is a marker found in hair follicle stem cells in various species and is important for hair growth and skin repair.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

New nanocarriers were developed for safer, targeted drug delivery and diagnostics, showing promise for future medical use.

The SA-MS hydrogel is a promising material for improving wound healing and skin regeneration in diseases like diabetes and skin cancer.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Plastic surgeons need to understand skin anatomy and physiology to effectively treat aging and diverse skin types.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Safe treatments like minoxidil and spironolactone can help manage hair loss in breast cancer patients without increasing cancer risk.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

New treatments are making advanced prostate cancer management more complex but also more hopeful.